Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27888690 | 0.89 | POLB (0.58) | POLBALDH1A1MAPTPKMHTT | |
| SCHEMBL24872490 | 0.85 | PAOX (0.50) | POLBALDH1A1MAPTL3MBTL1TERT | |
| SCHEMBL14622532 | 0.78 | PAOX (0.52) | POLBALDH1A1MAPTPKMHTT | |
| SCHEMBL2113757 | 0.78 | GLA (0.55) | POLBALDH1A1PKMHTTL3MBTL1 | |
| SCHEMBL13529059 | 0.78 | — | — | |
| SCHEMBL19658287 | 0.78 | MAPT (0.54) | POLBALDH1A1MAPTPKMHTT | |
| SCHEMBL14851410 | 0.77 | L3MBTL1 (0.63) | POLBALDH1A1MAPTPKMHTT | |
| Hydrochloric Acid SCHEMBL8743075 | 0.75 | L3MBTL1 (0.61) | POLBPKMHTTL3MBTL1KMT2A | |
| SCHEMBL27976392 | 0.75 | PKM (0.54) | POLBALDH1A1MAPTPKMHTT | |
| SCHEMBL17068270 | 0.73 | PKM (0.45) | POLBALDH1A1MAPTPKMHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230011571-A1 | SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS DISEASES | BP ASSET V, INC. (US) | 2023-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230011571-A1 | SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS DISEASES | FURIN, LGMN, PLAU | POLB 2597/4885ALDH1A1 4544/4885MAPT 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.